BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 23420139)

  • 1. Nodular regenerative hyperplasia in common variable immunodeficiency.
    Fuss IJ; Friend J; Yang Z; He JP; Hooda L; Boyer J; Xi L; Raffeld M; Kleiner DE; Heller T; Strober W
    J Clin Immunol; 2013 May; 33(4):748-58. PubMed ID: 23420139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrum of Hepatic Manifestations of Common Variable Immunodeficiency.
    Crotty R; Taylor MS; Farmer JR; Kakar S; Yilmaz F; Ardeniz Ö; Patil DT; Deshpande V
    Am J Surg Pathol; 2020 May; 44(5):617-625. PubMed ID: 32187043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver Stiffness by Transient Elastography Correlates With Degree of Portal Hypertension in Common Variable Immunodeficiency Patients With Nodular Regenerative Hyperplasia.
    DiGiacomo DV; Shay JE; Crotty R; Yang N; Bloom P; Corey K; Barmettler S; Farmer JR
    Front Immunol; 2022; 13():864550. PubMed ID: 35603209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nodular regenerative hyperplasia associated with common variable immunodeficiency and other comorbidities].
    León R; Sánchez-Martínez R; Palazón JM; Payá A; Ramos JM; Pinargote H
    Med Clin (Barc); 2016 Mar; 146(6):263-6. PubMed ID: 26723943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical manifestations and approach to the management of patients with common variable immunodeficiency and liver disease.
    Daza-Cajigal V; Segura-Guerrero M; López-Cueto M; Robles-Marhuenda Á; Camara C; Gerra-Galán T; Gómez-de-la-Torre R; Avendaño-Monje CL; Sánchez-Ramón S; Bosque-Lopez MJ; Quintero-Duarte A; Bonet-Vidal ML; Pons J
    Front Immunol; 2023; 14():1197361. PubMed ID: 37342345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common Variable Immunodeficiency and Liver Involvement.
    Song J; Lleo A; Yang GX; Zhang W; Bowlus CL; Gershwin ME; Leung PSC
    Clin Rev Allergy Immunol; 2018 Dec; 55(3):340-351. PubMed ID: 28785926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver disease accompanied by enteropathy in common variable immunodeficiency: Common pathophysiological mechanisms.
    Lima FMS; Toledo-Barros M; Alves VAF; Duarte MIS; Takakura C; Bernardes-Silva CF; Marinho AKBB; Grecco O; Kalil J; Kokron CM
    Front Immunol; 2022; 13():933463. PubMed ID: 36341360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and clinical significance of nodular regenerative hyperplasia in liver biopsies.
    Barge S; Grando V; Nault JC; Broudin C; Beaugrand M; Ganne-Carrié N; Roulot D; Ziol M
    Liver Int; 2016 Jul; 36(7):1059-66. PubMed ID: 26415006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Prevalence of Nodular Regenerative Hyperplasia in Inflammatory Bowel Disease Patients Treated with Thioguanine Is Not Associated with Clinically Significant Liver Disease.
    van Asseldonk DP; Jharap B; Verheij J; den Hartog G; Westerveld DB; Becx MC; Russel MG; Engels LG; de Jong DJ; Witte BI; Mulder CJ; van Nieuwkerk CM; Bloemena E; de Boer NK; van Bodegraven AA
    Inflamm Bowel Dis; 2016 Sep; 22(9):2112-20. PubMed ID: 27482972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrasinusoidal cytotoxic CD8+ T cells in nodular regenerative hyperplasia of the liver.
    Ziol M; Poirel H; Kountchou GN; Boyer O; Mohand D; Mouthon L; Tepper M; Guillet JG; Guettier C; Raphael M; Beaugrand M
    Hum Pathol; 2004 Oct; 35(10):1241-51. PubMed ID: 15492992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nodular regenerative hyperplasia in X-linked agammaglobulinemia: An underestimated and severe complication.
    Nunes-Santos CJ; Koh C; Rai A; Sacco K; Marciano BE; Kleiner DE; Marko J; Bergerson JRE; Stack M; Rivera MM; Constantine G; Strober W; Uzel G; Fuss IJ; Notarangelo LD; Holland SM; Rosenzweig SD; Heller T
    J Allergy Clin Immunol; 2022 Jan; 149(1):400-409.e3. PubMed ID: 34087243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mild changes of hepatic nodular regenerative hyperplasia may cause portal hypertension and be visible on reticulin but not hematoxylin and eosin staining.
    Navale P; Gonzalez RS
    Virchows Arch; 2021 Dec; 479(6):1145-1152. PubMed ID: 34435237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Portal hypertension in common variable immunodeficiency disorders - a single center analysis on clinical and immunological parameter in 196 patients.
    Hanitsch LG; Steiner S; Schumann M; Wittke K; Kedor C; Scheibenbogen C; Fischer A
    Front Immunol; 2023; 14():1268207. PubMed ID: 38187397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common variable immunodeficiency disorder-related liver disease is common and results in portal hypertension and an increased risk of death.
    Halliday N; Eden N; Somers H; Burke N; Silva H; Brito CG; Hall A; Quaglia A; Burns SO; Lowe DM; Thorburn D
    Hepatol Commun; 2024 Jan; 8(1):. PubMed ID: 38099861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nodular regenerative hyperplasia: the main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities.
    Malamut G; Ziol M; Suarez F; Beaugrand M; Viallard JF; Lascaux AS; Verkarre V; Bechade D; Poynard T; Hermine O; Cellier C
    J Hepatol; 2008 Jan; 48(1):74-82. PubMed ID: 17998147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common variable immunodeficiency disorder (CVID)-related liver disease: assessment of the main histological aspects using novel semiquantitative scoring systems, image analysis and correlation with clinical parameters of liver stiffness and portal hypertension.
    Silva H; Brito CGX; Hall A; Eden N; Somers H; Burke N; Burns SO; Lowe D; Thorburn D; Halliday N; Quaglia A
    J Clin Pathol; 2023 Aug; ():. PubMed ID: 37553247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical features of non-cirrhotic portal hypertension in patients with common variable immunodeficiency].
    Wu J; Han XX; Di H; Yin Y; Han YD; Wang Y; Zhang Y; Zeng XJ
    Zhonghua Nei Ke Za Zhi; 2023 Aug; 62(8):1007-1011. PubMed ID: 37528040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nodular regenerative hyperplasia related portal hypertension in a patient with hypogammaglobulinaemia.
    Lal BK; Stanley A
    World J Gastroenterol; 2013 Jun; 19(22):3502-4. PubMed ID: 23801845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nodular regenerative hyperplasia: evolving concepts on underdiagnosed cause of portal hypertension.
    Hartleb M; Gutkowski K; Milkiewicz P
    World J Gastroenterol; 2011 Mar; 17(11):1400-9. PubMed ID: 21472097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nodular regenerative hyperplasia of the liver: survival and associated features in a UK case series.
    Morris JM; Oien KA; McMahon M; Forrest EH; Morris J; Stanley AJ; Campbell S
    Eur J Gastroenterol Hepatol; 2010 Aug; 22(8):1001-5. PubMed ID: 20075739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.